BR6460727D0 - Processo para a fabricacao de novos amino acidos - Google Patents

Processo para a fabricacao de novos amino acidos

Info

Publication number
BR6460727D0
BR6460727D0 BR160727/64A BR16072764A BR6460727D0 BR 6460727 D0 BR6460727 D0 BR 6460727D0 BR 160727/64 A BR160727/64 A BR 160727/64A BR 16072764 A BR16072764 A BR 16072764A BR 6460727 D0 BR6460727 D0 BR 6460727D0
Authority
BR
Brazil
Prior art keywords
manufacture
amino acids
new amino
new
acids
Prior art date
Application number
BR160727/64A
Other languages
English (en)
Inventor
H Keberle
J Faigle
M Wilhelm
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH853763A external-priority patent/CH446376A/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of BR6460727D0 publication Critical patent/BR6460727D0/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR160727/64A 1963-07-09 1964-07-08 Processo para a fabricacao de novos amino acidos BR6460727D0 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH853763A CH446376A (de) 1963-07-09 1963-07-09 Verfahren zur Herstellung neuer Aminosäuren
CH672964 1964-05-22

Publications (1)

Publication Number Publication Date
BR6460727D0 true BR6460727D0 (pt) 1973-08-02

Family

ID=25700075

Family Applications (1)

Application Number Title Priority Date Filing Date
BR160727/64A BR6460727D0 (pt) 1963-07-09 1964-07-08 Processo para a fabricacao de novos amino acidos

Country Status (9)

Country Link
US (1) US3471548A (pt)
BE (1) BE650258A (pt)
BR (1) BR6460727D0 (pt)
CH (1) CH449645A (pt)
DE (1) DE1493536B1 (pt)
ES (1) ES301814A1 (pt)
FR (2) FR3677M (pt)
GB (1) GB1017439A (pt)
SE (4) SE333151B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956314A (en) * 1970-07-24 1976-05-11 U.C.B., Societe Anonyme Derivatives of 2-pyrrolidinone
US3978216A (en) * 1974-06-03 1976-08-31 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs
US3947579A (en) * 1974-06-03 1976-03-30 Nelson Research & Development Company Method and composition for potentiating neuroleptic drugs
US4084000A (en) * 1975-07-16 1978-04-11 Nelson Research And Development Company Method of treating schizophrenia
US4126684A (en) * 1976-02-11 1978-11-21 Ciba-Geigy Corporation 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
NL7706429A (nl) * 1977-06-10 1978-12-12 Univ Erasmus Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
NL8006135A (nl) * 1980-11-10 1982-06-01 Univ Erasmus Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel.
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents
US6051734A (en) * 1995-12-20 2000-04-18 Farmarc Nederland B.V. Process for the optical resolution of 3-(p-chlorophenyl)-glutaramide
DK0934061T6 (en) 1996-07-24 2015-01-26 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
AU2002215160A1 (en) 2000-11-30 2002-06-11 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
AU2002215159A1 (en) 2000-11-30 2002-06-11 Pfizer Products Inc. Combination of GABA agonists and sorbitol dehydrogenase inhibitors
WO2004100992A2 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
PT1660440E (pt) 2003-08-20 2012-05-15 Xenoport Inc Pró-fármacos de aciloxialquilcarbamato, métodos de síntese e utilização
PT1691811E (pt) 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
CA2553291A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. Combination of .gamma.-aminobutyric acid modulators and 5-ht1b receptor antagonists
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2058008B1 (en) 2006-08-11 2013-08-21 National University Corporation Nagoya University Anti-obesity agent and use thereof
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100145057A1 (en) * 2007-03-15 2010-06-10 Sun Pharma Advanced Research Company Ltd. Novel prodrugs
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
US20180208544A1 (en) 2015-07-13 2018-07-26 Piramal Enterprises Limited An improved process for the preparation of baclofen and its intermediate
CN106187794A (zh) * 2016-07-12 2016-12-07 安徽省逸欣铭医药科技有限公司 一种巴氯芬的绿色工业化生产方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125583A (en) * 1964-03-17 Hjnc oxchaxohxchc o oh

Also Published As

Publication number Publication date
ES301814A1 (es) 1965-01-01
FR3677M (fr) 1965-11-08
DE1493536B1 (de) 1971-10-14
BE650258A (pt) 1965-01-08
SE333151B (sv) 1971-03-08
GB1017439A (en) 1966-01-19
US3471548A (en) 1969-10-07
SE348460B (pt) 1972-09-04
CH449645A (de) 1968-01-15
SE348461B (pt) 1972-09-04
FR3692M (fr) 1965-11-15
SE348462B (pt) 1972-09-04

Similar Documents

Publication Publication Date Title
BR6460727D0 (pt) Processo para a fabricacao de novos amino acidos
BR6458580D0 (pt) Processo para a preparacao de azadibenzo-ciclo-heptenos 5-substituidos
BR6466023D0 (pt) Processo para a preparacao de novos compostos de acidos indolil-alfa amino aceticos substituidos
BR6465569D0 (pt) Processo para a producao de 1-glicosil-5-azacitozinas
BR6463480D0 (pt) Processo para a preparacao de novos diidronaftalenos
BR6465649D0 (pt) Processo para a fabricacao de novos 17-alcovil estradiois estrogenios altamente ativos
BR6457033D0 (pt) Um processo para a preparacao de aminoacetil-penicilinas
BR6460648D0 (pt) Processo para a preparacao de 19-alcoil-esteroides
BR6458845D0 (pt) Processo para a producao de compostos de naftaleno
BR6464536D0 (pt) Processo para a fabricacao de amino-compostos
BR6461880D0 (pt) Processo para a preparacao de um 2-guanidino-alcoil-cromano
BR6682750D0 (pt) Processo para a fabricacao de acidos azetidino-tiazolidinometano carboxilicos
BR6458631D0 (pt) Processo para a producao de polissacaridio
BR6459782D0 (pt) Processo para a preparacao de um novo polipeptido
BR6458097D0 (pt) Processo para a preparacao de novos polipeptideos
BR6463076D0 (pt) Processo para a producao de vacinas
BR6460973D0 (pt) Processo para a producao de 2 1-benziso-tiazois
BR6463332D0 (pt) Processo para a preparacao de esteres
BR6456924D0 (pt) Novo processo para a fabricacao de amino-compostos
BR6464789D0 (pt) Processo para a fabricacao de 5-nitro-imidazois
BR6456819D0 (pt) Processo para a preparacao de galacturonidios de esteroid
BR7017560D0 (pt) Processo para a preparacao de 1-hidroxi-2-amino -1- fenilal-canos substituidos
BR6456037D0 (pt) Processo para a producao de derivados c-halo de amino-acidos
BR6355060D0 (pt) Processo para a preparacao de acidos amino carboxilicos
BR6459217D0 (pt) Processo para a fabricacao de novos 7-alfa-metil-androstenos